ATE328597T1 - Arzneimittel zur verminderung der effekte während oder nach der menopause und verfahren tur behandlung under verwendung derselben - Google Patents

Arzneimittel zur verminderung der effekte während oder nach der menopause und verfahren tur behandlung under verwendung derselben

Info

Publication number
ATE328597T1
ATE328597T1 AT99450012T AT99450012T ATE328597T1 AT E328597 T1 ATE328597 T1 AT E328597T1 AT 99450012 T AT99450012 T AT 99450012T AT 99450012 T AT99450012 T AT 99450012T AT E328597 T1 ATE328597 T1 AT E328597T1
Authority
AT
Austria
Prior art keywords
menopause
post
reducing
treatment
methods
Prior art date
Application number
AT99450012T
Other languages
English (en)
Inventor
Jack Auzerie
Original Assignee
Amistad Pharma Sas
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Amistad Pharma Sas filed Critical Amistad Pharma Sas
Application granted granted Critical
Publication of ATE328597T1 publication Critical patent/ATE328597T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
AT99450012T 1998-06-02 1999-06-02 Arzneimittel zur verminderung der effekte während oder nach der menopause und verfahren tur behandlung under verwendung derselben ATE328597T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9807051A FR2779062A1 (fr) 1998-06-02 1998-06-02 Preparation sous forme galenique simple visant a limiter les effets induits durant la menopause et posterieurement et traitement avec cette preparation

Publications (1)

Publication Number Publication Date
ATE328597T1 true ATE328597T1 (de) 2006-06-15

Family

ID=9527031

Family Applications (1)

Application Number Title Priority Date Filing Date
AT99450012T ATE328597T1 (de) 1998-06-02 1999-06-02 Arzneimittel zur verminderung der effekte während oder nach der menopause und verfahren tur behandlung under verwendung derselben

Country Status (7)

Country Link
EP (1) EP0968717B1 (de)
AT (1) ATE328597T1 (de)
DE (1) DE69931696T2 (de)
DK (1) DK0968717T3 (de)
ES (1) ES2267241T3 (de)
FR (1) FR2779062A1 (de)
PT (1) PT968717E (de)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006013464A1 (en) * 2004-07-27 2006-02-09 Amistad Pharma Sas Hormone replacement therapy comprising a combination of 17-beta-oestradiol and chlormadinone acetate

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH674618A5 (de) * 1987-04-02 1990-06-29 Ciba Geigy Ag
DE4019670A1 (de) * 1990-06-22 1992-01-09 Erhard Dr Med Roemer Arzneimittel zur behandlung der wechseljahre der frau
SE9403389D0 (sv) * 1994-10-06 1994-10-06 Astra Ab Pharmaceutical composition containing derivattves of sex hormones
DE19526864A1 (de) * 1995-07-22 1997-01-23 Labtec Gmbh Hormonpflaster

Also Published As

Publication number Publication date
DE69931696T2 (de) 2007-06-14
EP0968717A1 (de) 2000-01-05
PT968717E (pt) 2006-09-29
EP0968717B1 (de) 2006-06-07
ES2267241T3 (es) 2007-03-01
FR2779062A1 (fr) 1999-12-03
DE69931696D1 (de) 2006-07-20
DK0968717T3 (da) 2006-08-14

Similar Documents

Publication Publication Date Title
MX9704030A (es) 1,1-dioxidos de 2-heterocicliloxi y tiometil-1,2,5-tiadiazolidin-3-ona y composiciones y metodo de uso de los mismos.
HU913193D0 (en) 17betha-substituted 4-aza-5alpha-androstane-3-on derivatives, process for their production and for the production of medical preparations containing them
GEP20012375B (en) Isothiazolones, Pharmaceutical Composition on Their Basis and Method for Obtaining the Same
DE3684409D1 (de) Verwendung von gamma-linolensaeure und verwandten verbindungen zur herstellung eubnes arzneimittels zur behandlung von endometriose.
PL317105A1 (en) Compositions containing dna and p53 damaging agents
ATE170077T1 (de) Verfahren zur behandlung von krebs durch kombinationstherapie mit 2'- halomethylidenderivaten und einem s- oder m-phase spezifischen antineoplastischen wirkstoff
NO972391L (no) 2-substituerte 1,2,5-tiadiazolidin-3-on 1,1-dioksider og preparater og metoder for anvendelse derav
DE69509843D1 (de) Apparat zur Behandlung z.B. von Poststücken
KR0156686B1 (en) Pharmaceutical composition comprising aryl-substituted rhodanine derivatives
DE59300236D1 (de) Verfahren zur Herstellung von Tantal(v)-nitrid und dessen Verwendung.
KR950700310A (ko) 헤테로트리사이클릭 유도체, 그의 제조방법 및 그를 함유하는 약제학적 조성물(heterotricyclic derivatives, process for their preparation and pharmaceutical compositions containing them)
NO972449L (no) Substituerte 2-arylkarbonyloksymetyl-1,2,5-tiadiazolidin-3-on-1,1-dioksidderivater og preparater og fremgangsmåte for anvendelse derav
MY129782A (en) Novel medical use
DE58904722D1 (de) Arzneimittelzubereitung aus esterderivaten des hecogenins und dessen verwendung zur behandlung von benigner prostatahyperplasie.
DE60005952T8 (de) Lösliche hla-g enthaltende zusammensetzungen zur behandlung entzündlicher hautkrankheiten
EP0674905A3 (de) Bacterin zur Behandlung von Necrophorum-Krankheiten und Verfahren zur Herstellung.
DE59010302D1 (de) R-(-)-1-(5-Hydroxyhexyl)-3-methyl-7-propylxanthin, Verfahren zu dessen Herstellung und diese Verbindung enthaltende Arzneimittel
ATE328597T1 (de) Arzneimittel zur verminderung der effekte während oder nach der menopause und verfahren tur behandlung under verwendung derselben
DE69526584D1 (de) Verwendung von immunosuppressiva zur behandlung der schizophrenie
GR3017967T3 (en) Substituted pyrido-oxazines.
DE69109243D1 (de) Verfahren zur Herstellung von L-Tryptophan und L-Threonine.
AU7770991A (en) Method and composition for the treatment of cancer
FI952203L (fi) Sykloheksaanijohdannaiset, menetelmä niiden valmistamiseksi ja yhdisteiden käyttö sairauksien hoitamiseksi
NO972450L (no) Substituerte 2-(fosfinyloksymetyl)-1,2,5-tiadiazolidin-3-on 1,1-dioksider og preparater og metode for anvendelse derav
ATE201679T1 (de) 6-methoxy-1h-benzotriazol-5-carboxamid-derivate verfahren zur herstellung und diese enthaltende arzneimittel

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 0968717

Country of ref document: EP

REN Ceased due to non-payment of the annual fee